Detalhe da pesquisa
1.
PUM1 and RNase P genes as potential cell-free DNA markers in breast cancer.
J Clin Lab Anal
; 35(4): e23720, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33522650
2.
Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
Breast J
; 26(9): 1659-1666, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713113
3.
Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience.
PLoS One
; 19(2): e0293833, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300959
4.
Characteristics of gastric cancer around the world.
Crit Rev Oncol Hematol
; 181: 103841, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240980
5.
Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru.
Front Oncol
; 13: 1227864, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664050
6.
Promoter hypermethylation of RARB and GSTP1 genes in plasma cell-free DNA as breast cancer biomarkers in Peruvian women.
Mol Genet Genomic Med
; 11(12): e2260, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548362
7.
A nationwide pilot study on breast cancer screening in Peru.
Ecancermedicalscience
; 17: 1494, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816782
8.
Sex, immunity, and cancer.
Biochim Biophys Acta Rev Cancer
; 1877(1): 188647, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767966
9.
Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077821
10.
Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer.
Ecancermedicalscience
; 16: 1387, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35919233
11.
Chip-based digital Polymerase Chain Reaction as quantitative technique for the detection of PIK3CA mutations in breast cancer patients.
Heliyon
; 8(11): e11396, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36387506
12.
Oncological Care During First Peruvian National Emergency COVID-19 Pandemic: A Multicentric Descriptive Study.
Cancer Manag Res
; 14: 1075-1085, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35300062
13.
Profile of entrectinib in the treatment of ROS1-positive non-small cell lung cancer: Evidence to date.
Hematol Oncol Stem Cell Ther
; 14(3): 192-198, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290717
14.
PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report.
World J Clin Oncol
; 12(8): 702-711, 2021 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34513603
15.
Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
Clin Breast Cancer
; 21(3): 239-246.e4, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221201
16.
Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors.
Front Oncol
; 11: 752918, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737960
17.
Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer.
PLoS One
; 15(12): e0243447, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284847
18.
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
PLoS One
; 15(8): e0237811, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833983
19.
ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer.
Crit Rev Oncol Hematol
; 136: 48-55, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30878128
20.
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer.
Clin Med Insights Oncol
; 13: 1179554919868482, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31447598